148 related articles for article (PubMed ID: 28344615)
1. Usefulness of the platelet-to-lymphocyte ratio in predicting long-term cardiovascular mortality in patients with peripheral arterial occlusive disease.
Uzun F; Erturk M; Cakmak HA; Kalkan AK; Akturk IF; Yalcin AA; Uygur B; Bulut U; Oz K
Postepy Kardiol Interwencyjnej; 2017; 13(1):32-38. PubMed ID: 28344615
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease.
Erturk M; Cakmak HA; Surgit O; Celik O; Aksu HU; Akgul O; Gurdogan M; Bulut U; Ozalp B; Akbay E; Yildirim A
J Cardiol; 2014 Nov; 64(5):371-6. PubMed ID: 24685686
[TBL] [Abstract][Full Text] [Related]
3. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.
Gary T; Pichler M; Belaj K; Hafner F; Gerger A; Froehlich H; Eller P; Rief P; Hackl G; Pilger E; Brodmann M
PLoS One; 2013; 8(7):e67688. PubMed ID: 23844064
[TBL] [Abstract][Full Text] [Related]
4. Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent.
Cho KI; Ann SH; Singh GB; Her AY; Shin ES
PLoS One; 2015; 10(7):e0133934. PubMed ID: 26207383
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of platelet to lymphocyte and neutrophil to lymphocyte ratios in predicting the presence of cerebral venous sinus thrombosis and in-hospital major adverse cerebral events.
Akboga YE; Bektas H; Anlar O
J Neurol Sci; 2017 Sep; 380():226-229. PubMed ID: 28870575
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Platelet-to-Lymphocyte Ratio to Predict Long-Term All-Cause Mortality in Patients at High Risk of Coronary Artery Disease Who Underwent Coronary Angiography.
Lee YSG; Baradi A; Peverelle M; Sultani R; Adams H; Garlick J; Wilson AM
Am J Cardiol; 2018 May; 121(9):1021-1026. PubMed ID: 29606325
[TBL] [Abstract][Full Text] [Related]
7. Platelet-to-lymphocyte ratio is a predictor of long-term mortality in patients with acute coronary syndrome.
Oylumlu M; Oylumlu M; Arslan B; Polat N; Özbek M; Demir M; Yildiz A; Toprak N
Postepy Kardiol Interwencyjnej; 2020 Jun; 16(2):170-176. PubMed ID: 32636901
[TBL] [Abstract][Full Text] [Related]
8. Platelet/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention.
Toprak C; Tabakci MM; Simsek Z; Arslantas U; Durmus HI; Ocal L; Demirel M; Ozturkeri B; Ozal E; Kargin R
Postepy Kardiol Interwencyjnej; 2015; 11(4):288-97. PubMed ID: 26677378
[TBL] [Abstract][Full Text] [Related]
9. Platelet-to-lymphocyte ratio predicts mortality better than neutrophil-to-lymphocyte ratio in hemodialysis patients.
Yaprak M; Turan MN; Dayanan R; Akın S; Değirmen E; Yıldırım M; Turgut F
Int Urol Nephrol; 2016 Aug; 48(8):1343-1348. PubMed ID: 27118565
[TBL] [Abstract][Full Text] [Related]
10. Platelet-to-lymphocyte ratio is associated with cardiovascular disease in continuous ambulatory peritoneal dialysis patients.
Chen T; Yang M
Int Immunopharmacol; 2020 Jan; 78():106063. PubMed ID: 31835088
[TBL] [Abstract][Full Text] [Related]
11. Platelet-to-lymphocyte ratio as a novel marker of in-hospital and long-term adverse outcomes among patients with acute pulmonary embolism: A single center large-scale study.
Ozcan Cetin EH; Cetin MS; Canpolat U; Akdi A; Aras D; Temizhan A; Aydogdu S
Thromb Res; 2017 Feb; 150():33-40. PubMed ID: 28011405
[TBL] [Abstract][Full Text] [Related]
12. The age-specific prognostic impact of the platelet-to-lymphocyte ratio on long-term outcome after acute coronary syndrome.
Kazem N; Hofer F; Koller L; Hammer A; Hofbauer TM; Hengstenberg C; Niessner A; Sulzgruber P
Eur Heart J Open; 2022 Jan; 2(1):oeab031. PubMed ID: 35919656
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as independent predictors of outcome in infective endocarditis (IE).
Meshaal MS; Nagi A; Eldamaty A; Elnaggar W; Gaber M; Rizk H
Egypt Heart J; 2019 Sep; 71(1):13. PubMed ID: 31659520
[TBL] [Abstract][Full Text] [Related]
14. Platelet to Lymphocyte Ratio on Admission and Prognosis in Patients with Acute Cardiogenic Pulmonary Edema.
Demir M; Duyuler PT; Guray U; Celik MC
J Emerg Med; 2018 Oct; 55(4):465-471. PubMed ID: 30115388
[TBL] [Abstract][Full Text] [Related]
15. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.
Que Y; Qiu H; Li Y; Chen Y; Xiao W; Zhou Z; Zhang X
BMC Cancer; 2015 Oct; 15():648. PubMed ID: 26432433
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of the platelet-to-lymphocyte ratio in acute coronary syndrome: a systematic review and meta-analysis.
Li H; Zhou Y; Ma Y; Han S; Zhou L
Kardiol Pol; 2017; 75(7):666-673. PubMed ID: 28394006
[TBL] [Abstract][Full Text] [Related]
17. Platelet to Lymphocyte Ratio in Cardiovascular Diseases: A Systematic Review.
Kurtul A; Ornek E
Angiology; 2019 Oct; 70(9):802-818. PubMed ID: 31030530
[TBL] [Abstract][Full Text] [Related]
18. Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease.
Zhen Y; Chang Z; Liu Z; Zheng J
BMC Cardiovasc Disord; 2020 Jan; 20(1):9. PubMed ID: 31918662
[TBL] [Abstract][Full Text] [Related]
19. The platelet-lymphocyte ratio: A simple, inexpensive and rapid prognostic marker for cardiovascular events.
Balta S; Ozturk C
Platelets; 2015; 26(7):680-1. PubMed ID: 25549287
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
